// Company Overview //
| Stock Name | 醫渡科技有限公司 |
| Stock Code | 02158 |
| Company Full Name | 醫渡科技有限公司 |
| Industry | 軟件服務 |
| Principal Activities | 主要於中國為醫療行業提供大數據平臺和解決方案、生命科學解決方案及健康管理平臺和解決方案。 |
| Listing Date | 2021-01-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市海淀區花園北路9號樓健康智谷大廈8層 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | http://www.yidutechgroup.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2020-12-31 |
| Offer Price | HK$ 26.30 / shares |
| Total Funds Raised | HK$ 2,057,317,500 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 58.25 |
| First Day Change | 147.91% |
| First Day Volume | 113267000.0 |
| First Day Turnover | 7093330000.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約35%(約1,488.4百萬港元)用于持續加強我們的核心能力,包括數據處理技術和機器學習算法,并提升我們提供客戶所需解決方案的能力;
2、約35%(約1,488.4百萬港元)用于為業務運營提供資金及進一步進行業務擴張,包括為現有及新市場開發新的應用和解決方案以及在現有或新市 場中銷售及營銷該等新應用程序及解決方案;
3、約20%(約850.5百萬港元)用于通過戰略合伙、投資和收購來進一步豐富我們的生態系統;
4、約10%(約425.3百萬港元)用作營運資金及一般企業用途。 |
// Underwriting Syndicate //
联席保荐人 (2)
高盛(亚洲)有限责任公司
中国国际金融香港证券有限公司
整体协调人 (3)
高盛(亚洲)有限责任公司
中国国际金融香港证券有限公司
花旗环球金融亚洲有限公司
联席账簿管理人 (3)
高盛(亚洲)有限责任公司
中国国际金融香港证券有限公司
花旗环球金融亚洲有限公司
联席牵头经办人 (4)
高盛(亚洲)有限责任公司
中国国际金融香港证券有限公司
花旗环球金融亚洲有限公司
招商证券(香港)有限公司
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
3W Funds |
155,009,570 HKD |
— |
3.77% |
— |
6 months |
2021-07-15 |
| 2 |
China Orient Multi-Strategy Master Fund |
77,503,470 HKD |
— |
1.88% |
— |
6 months |
2021-07-15 |
| 3 |
Matthews Asia Funds |
155,009,570 HKD |
— |
3.77% |
— |
6 months |
2021-07-15 |
| 4 |
OrbiMed Funds |
310,021,770 HKD |
— |
7.53% |
— |
6 months |
2021-07-15 |
| 5 |
Tencent Mobility Limited |
155,009,570 HKD |
— |
3.77% |
— |
6 months |
2021-07-15 |
| 6 |
Velmar Company Limited |
155,009,570 HKD |
— |
3.77% |
— |
6 months |
2021-07-15 |
| 7 |
Yaqut Sdn Bhd |
310,021,770 HKD |
— |
7.53% |
— |
6 months |
2021-07-15 |
| 8 |
加拿大退休金计划投资委员会 |
310,021,770 HKD |
— |
7.53% |
— |
6 months |
2021-07-15 |
// Directors & Management //
| Chairman | 宮盈盈 |
| Company Secretary | 白蕊;李菁怡 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 宮盈盈(42.21%);陽光人壽保險股份有限公司(9.73%);Meddig International(6.00%);新加坡政府投資有限公司(5.95%);MSA Management Holdings Pte. Ltd.(5.18%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.